Patents by Inventor Taku Numazawa

Taku Numazawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Complex comprising OCIF and polysaccharide
    Publication number: 20060084595
    Abstract: A complex comprising at least one substance selected from the group consisting of an osteoclastogenesis inhibitory factor, an analogue thereof and a variant thereof, which is bound to at least one substance selected from the group consisting of a polysaccharide and a polysaccharide derivative. The complex has a prolonged retention in the bloodstream after administration, making it useful in the treatment and prophylaxis of bone metabolic diseases.
    Type: Application
    Filed: October 21, 2005
    Publication date: April 20, 2006
    Inventors: Shinichi Yamamoto, Junichi Okada, Atsushi Kurihara, Taku Numazawa, Junichi Kondo, Eisuke Tsuda, Shinichi Mochizuki, Hirotaka Nishi, Hideki Miyazaki
  • Complex comprising OCIF and polysaccharide
    Publication number: 20030139325
    Abstract: A complex comprising at least one substance selected from the group consisting of an osteoclastogenesis inhibitory factor, an analogue thereof and a variant thereof, which is bound to at least one substance selected from the group consisting of a polysaccharide and a polysaccharide derivative. The complex has a prolonged retention in the bloodstream after administration, making it useful in the treatment and prophylaxis of bone metabolic diseases.
    Type: Application
    Filed: February 11, 2003
    Publication date: July 24, 2003
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Shinichi Yamamoto, Junichi Okada, Atsushi Kurihara, Taku Numazawa, Junichi Kondo, Eisuke Tsuda, Shinichi Mochizuki, Hirotaka Nishi, Hideki Miyazaki
  • Complex comprising OCIF and polysaccharide
    Publication number: 20030045456
    Abstract: A complex comprising at least one substance selected from the group consisting of an osteoclastogenesis inhibitory factor, an analogue thereof and a variant thereof, which is bound to at least one substance selected from the group consisting of a polysaccharide and a polysaccharide derivative. The complex has a prolonged retention in the bloodstream after administration, making it useful in the treatment and prophylaxis of bone metabolic diseases.
    Type: Application
    Filed: June 27, 2002
    Publication date: March 6, 2003
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Shinichi Yamamoto, Junichi Okada, Atsushi Kurihara, Taku Numazawa, Junichi Kondo, Eisuke Tsuda, Shinichi Mochizuki, Hirotaka Nishi, Hideki Miyazaki